1. Home
  2. PLSE vs CIM Comparison

PLSE vs CIM Comparison

Compare PLSE & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • CIM
  • Stock Information
  • Founded
  • PLSE 2014
  • CIM 2007
  • Country
  • PLSE United States
  • CIM United States
  • Employees
  • PLSE N/A
  • CIM N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • CIM Real Estate Investment Trusts
  • Sector
  • PLSE Health Care
  • CIM Real Estate
  • Exchange
  • PLSE Nasdaq
  • CIM Nasdaq
  • Market Cap
  • PLSE 1.1B
  • CIM 1.2B
  • IPO Year
  • PLSE 2016
  • CIM 2007
  • Fundamental
  • Price
  • PLSE $17.64
  • CIM $14.27
  • Analyst Decision
  • PLSE
  • CIM Hold
  • Analyst Count
  • PLSE 0
  • CIM 1
  • Target Price
  • PLSE N/A
  • CIM $16.00
  • AVG Volume (30 Days)
  • PLSE 154.0K
  • CIM 590.6K
  • Earning Date
  • PLSE 10-30-2024
  • CIM 02-12-2025
  • Dividend Yield
  • PLSE N/A
  • CIM 10.41%
  • EPS Growth
  • PLSE N/A
  • CIM 117.60
  • EPS
  • PLSE N/A
  • CIM 3.36
  • Revenue
  • PLSE N/A
  • CIM $442,341,000.00
  • Revenue This Year
  • PLSE N/A
  • CIM N/A
  • Revenue Next Year
  • PLSE N/A
  • CIM $11.33
  • P/E Ratio
  • PLSE N/A
  • CIM $4.23
  • Revenue Growth
  • PLSE N/A
  • CIM 44.27
  • 52 Week Low
  • PLSE $6.60
  • CIM $11.29
  • 52 Week High
  • PLSE $22.69
  • CIM $16.89
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 46.65
  • CIM 49.21
  • Support Level
  • PLSE $17.19
  • CIM $13.38
  • Resistance Level
  • PLSE $18.72
  • CIM $14.47
  • Average True Range (ATR)
  • PLSE 1.05
  • CIM 0.31
  • MACD
  • PLSE -0.09
  • CIM 0.03
  • Stochastic Oscillator
  • PLSE 20.49
  • CIM 81.65

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About CIM Chimera Investment Corporation

Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.

Share on Social Networks: